BRCA1/2 Germline Mutations in Jewish Patients With Uterine Serous Carcinoma
Ilan Bruchim(Meir Medical Center), Ami Fishman(Tel Aviv University), Zohar Attias(Tel Aviv University), Eitan Friedman(University of Pennsylvania), Dvora Kidron(Meir Medical Center), Keren Amichay(Gynecologic Oncology Group), Haim Werner(Tel Aviv University), Tal Biron‐Shental(Tel Aviv University), Liat Drucker(Meir Medical Center)
Cited by 47
Related Papers
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer
|JAMA|2015|513
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
|British Journal of Cancer|2014|444
Mutational spectrum in a worldwide study of 29,700 families with<i>BRCA1</i>or<i>BRCA2</i>mutations
|Human Mutation|2018|319
Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
|The American Journal of Human Genetics|2008|284
Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine
|Journal of Clinical Investigation|2021|252